explore -WSS

explore

author：explore 2025-10-02 00:28:59 - browse：4438

Editor’s note: A recording of the event is embedded below.

Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings? What key signals will indicate how biosimilars might be prescribed, or paid for?

Let’s dive in and discuss what to watch in the months ahead.

Speakers:

Alex Brill, CEO, Matrix Global Advisors
Chris Brown, managing partner and co-founder, Integrity Rx Partners
Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)
Thomas Newcomer, head of U.S. market access, Samsung Bioepis (sponsor speaker)

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Patients, doctors press FTC to beef up hospital merger scrutiny

entertainment

WSS

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Blood tests recalled over risk of missed heart attack diagnosis

Eli Lilly CEO gives to Mike Pence presidential super PAC

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Involuntary treatment for addiction doesn't work

FDA panel to weigh safety of artificial wombs for preterm births

hotspot

explore

knowledge

Activists slam private health insurers over coverage restrictions

Eli Lilly to acquire Versanis in heated race for weight loss drugs

23andMe had bad news about my health. I wish a person had delivered it

David Liu startup to focus on CRISPR delivery

Wildfire smoke exposes gaps in outdoor worker protections

The new HIV moral panic

Dobbs anniversary: the lost opportunity of abortion as health care

Care demand spikes challenge UnitedHealth’s provider arm

Medicare details structure of new drug price negotiation program

The new HIV moral panic

focus

Akili changes sales model for its ADHD video game treatment

What happened to the House vote on health price transparency?

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Grad students accuse University of California of wage theft

Involuntary treatment for addiction doesn't work

Neurocrine congenital adrenal hyperplasia trial succeeds

hotspot

entertainment

leisure time

Wikipedia